Biotech stocks are on fire.

That’s given some analysts flashbacks of 2000, when tech valuations were red hot, but it didn’t end well because they crashed.

Michael Batnick over at The Irrelevant InvestorĀ posted this chart Monday that compares the rally in tech stocks then to biotechs in recent years.

He describes the biotech rally:

“In the 168 weeks since the beginning of 2012, the NASDAQ Biotech Index has advanced 250%. In the 168 weeks leading up to the peak of the dot-com bubble, the NASDAQ Composite gained 290%. While the Biotech stocks have had a monster run and are approaching the dot-com gains, the rate at which they accelerated is peanuts compared to the tech stocks.”

This isn’t to say that the bull run will end like it did in 2000, he notes, and some analysts are calling for a breather.

On Monday, the ‘IBB’ ETF that tracks the biotech sector was a major laggard, falling about 2% while markets were broadly higher.

Here’s the chart.

Screen Shot 2015 03 23 at 1.06.21 PMThe Irrelevant Investor

Rules of Discussion on Nasdaq Futures

1. This forum is for discussion of financial markets. Please respect others view even if they are contrary to you.
2. Member's comments should lead to value addition in forum discussion.
3. If anyone is found making repetitive Explicit/Abusive/Racial comments, his account shall be banned and old posts will be deleted.
4. Providing Advice/Recommendations/Tips is fine but it should be free. Members cannot ask to be paid for it. Paid Advice is strictly prohibited
5. Spam links are not allowed. Too much promotion or using Contact info in ID will lead to account ban.
IMP : Members are requested to flag any violations to keep Forum Clean.

Loading comments …